Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Apr 27, 2021 4:06pm
250 Views
Post# 33076285

RE:RE:ALL IN ALL looks like a decent REPORT!

RE:RE:ALL IN ALL looks like a decent REPORT!If you just look at the 6 patients who recieved the optimized procedure in phase 2 it is still possible to hit 83% CR at 180 days for that population.

If you include the 7 patients still to come before we reach 25 (13 patients with optimized treatment), it is still possible to achieve 92% CR at 180 days.

Not likely - but not impossible. For that you would need all of the last 10 patients of the 25 to be CR at 180 days.


enriquesuave wrote: Yes results look good for patients treated with optimized procedure.  We just need more data to confirm and get a better idea of exact efficacy numbers.  


<< Previous
Bullboard Posts
Next >>